Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(20):1553-1557; doi:10.1093/jnci/93.20.1553
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Bondy, M. L.
Right arrow Articles by Wei, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bondy, M. L.
Right arrow Articles by Wei, Q.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 20, 1553-1557, October 17, 2001
© 2001 Oxford University Press


REPORT

{gamma}-Radiation Sensitivity and Risk of Glioma

Melissa L. Bondy, Li-E. Wang, Randa El-Zein, Mariza de Andrade, Mano S. Selvan, Janet M. Bruner, Victor A. Levin, W. K. Alfred Yung, Phyllis Adatto, Qingyi Wei

Affiliations of authors: M. L. Bondy, L.-E. Wang, R. El-Zein, M. S. Selvan, P. Adatto, Q. Wei (Department of Epidemiology), J. M. Bruner (Department of Pathology), V. A. Levin, W. K. A. Yung (Department of Neuro-Oncology), The University of Texas M. D. Anderson Cancer Center, Houston; M. de Andrade, Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, MN.

Correspondence to: Melissa L. Bondy, Ph.D., Department of Epidemiology, Box 189, The University of Texas M. D. Anderson Cancer Center, Houston, TX (e-mail: mbondy{at}mdanderson.org).

Background: About 9% of human cancers are brain tumors, of which 90% are gliomas. {gamma}-Radiation has been identified as a risk factor for brain tumors. In a previous pilot study, we found that lymphocytes from patients with glioma were more sensitive to {gamma}-radiation than were lymphocytes from matched control subjects. In this larger case–control study, we compared the {gamma}-radiation sensitivity of lymphocytes from glioma patients with those from control subjects and investigated the association between mutagen sensitivity and the risk for developing glioma. Methods: We used a mutagen sensitivity assay (an indirect measure of DNA repair activity) to assess chromosomal damage. We {gamma}-irradiated (1.5 Gy) short-term lymphocyte cultures from 219 case patients with glioma and from 238 healthy control subjects frequency matched by age and sex. After irradiation, cells were cultured for 4 hours, and then Colcemid was added for 1 hour to arrest cells in mitosis. Fifty metaphases were randomly selected for each sample and scored for chromatid breaks. All statistical tests were two-sided. Results: We observed a statistically significantly higher frequency of chromatid breaks per cell from case patients with glioma (mean = 0.55; 95% confidence interval [CI] = 0.50 to 0.59) than from control subjects (mean = 0.44; 95% CI = 0.41 to 0.48) (P<.001). Using 0.40 (the median number of chromatid breaks per cell in control subjects) as the cut point for defining mutagen sensitivity and adjusting for age, sex, and smoking status, we found that mutagen sensitivity was statistically significantly associated with an increased risk for glioma (odds ratio = 2.09; 95% CI = 1.43 to 3.06). When the data were divided into tertiles, the relative risk for glioma increased from the lowest tertile to the highest tertile (trend test, P<.001). Conclusion: {gamma}-Radiation-induced mutagen sensitivity of lymphocytes may be associated with an increased risk for glioma, a result that supports our earlier preliminary findings.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Neuro OncologyHome page
A. P. Kyritsis, M. L. Bondy, J. S. Rao, and C. Sioka
Inherited predisposition to glioma
Neuro Oncology, November 23, 2009; (2009) nop011v1.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Liu, M. E. Scheurer, R. El-Zein, Y. Cao, K.-A. Do, M. Gilbert, K. D. Aldape, Q. Wei, C. Etzel, and M. L. Bondy
Association and Interactions between DNA Repair Gene Polymorphisms and Adult Glioma
Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 204 - 214.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Leng, C. A. Stidley, A. M. Bernauer, M. A. Picchi, X. Sheng, M. A. Frasco, D. Van Den Berg, F. D. Gilliland, R. E. Crowell, and S. A. Belinsky
Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers
Carcinogenesis, July 1, 2008; 29(7): 1380 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-E Wang, P. Xiong, H. Zhao, M. R. Spitz, E. M. Sturgis, and Q. Wei
Chromosome Instability and Risk of Squamous Cell Carcinomas of Head and Neck
Cancer Res., June 1, 2008; 68(11): 4479 - 4485.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Liu, H. Zhang, K. Zhou, L. Chen, Z. Xu, Y. Zhong, H. Liu, R. Li, Y. Y. Shugart, Q. Wei, et al.
Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma
Carcinogenesis, September 1, 2007; 28(9): 1906 - 1913.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Lu, L.-E Wang, P. Xiong, E. M. Sturgis, M. R. Spitz, and Q. Wei
172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant
Carcinogenesis, May 1, 2007; 28(5): 988 - 994.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
E. Erdei, S.-J. Lee, Q. Wei, L.-E. Wang, Y.-S. Song, D. Bovbjerg, and M. Berwick
Reliability of mutagen sensitivity assay: an inter-laboratory comparison
Mutagenesis, July 1, 2006; 21(4): 261 - 264.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. G. Natarajan, N. Ganesan, P. Carter-Nolan, C. A. Tucker, P. G. Shields, and L. L. Adams-Campbell
{gamma}-Radiation-Induced Chromosomal Mutagen Sensitivity Is Associated with Breast Cancer Risk in African-American Women: Caffeine Modulates the Outcome of Mutagen Sensitivity Assay.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 437 - 442.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L.-E Wang, P. Xiong, S. S. Strom, L. H. Goldberg, J. E. Lee, M. I. Ross, P. F. Mansfield, J. E. Gershenwald, V. G. Prieto, J. N. Cormier, et al.
In Vitro Sensitivity to Ultraviolet B Light and Skin Cancer Risk: A Case-Control Analysis
J Natl Cancer Inst, December 21, 2005; 97(24): 1822 - 1831.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-E Wang, M. L. Bondy, H. Shen, R. El-Zein, K. Aldape, Y. Cao, V. Pudavalli, V. A. Levin, W. K. A. Yung, and Q. Wei
Polymorphisms of DNA Repair Genes and Risk of Glioma
Cancer Res., August 15, 2004; 64(16): 5560 - 5563.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M. S. Berger
Epidemiology of primary brain tumors: Current concepts and review of the literature
Neuro-oncol, October 1, 2002; 4(4): 278 - 299.
[Abstract] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. K. Nersesyan
Re: {gamma}-Radiation Sensitivity and Risk of Glioma
J Natl Cancer Inst, June 19, 2002; 94(12): 949 - 949.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. J. Dornfeld and T. S. Lawrence
A Predisposition Supposition for Glioma
J Natl Cancer Inst, October 17, 2001; 93(20): 1512 - 1513.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.